Stay updated on HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial
Sign up to get notified when there's something new on the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page.

Latest updates to the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe recruitment status is updated to 'No longer looking for participants,' indicating enrollment has ceased. New and updated sections—'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study'—along with a revision update to v3.6.0 and a formatting change from 'Intervention / Treatment' to 'Intervention/Treatment' are reflected on the page.SummaryDifference0.6%

- Check20 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a routine update to the page’s metadata.SummaryDifference0.1%

- Check41 days agoChange DetectedThe study page now shows a new revision label v3.5.4, replacing the previous v3.5.3, indicating an update to the study record rather than a change to the study details.SummaryDifference0.1%

- Check49 days agoChange DetectedA Publications section was added, listing a related article and noting that publications are automatically filled from PubMed; it includes the full citation and author names for reference.SummaryDifference0.3%

- Check56 days agoChange DetectedThe results status was updated from 'No Results Posted' to 'Results Submitted'. This reflects that the study's results have been submitted for review and are awaiting posting.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now shows revision v3.5.3, replacing the previous v3.5.0; this indicates a new version of the study record display without changing its substantive details.SummaryDifference0.1%

Stay in the know with updates to HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HD IL-2 + Anti-PD-1 for Anti-PD-1 Resistant MM & RCC Clinical Trial page.